In all non-tumor tissues, residual Pt (μg/g dried tissues) was lower in Tf-cisplatin treatment group compared to free cisplatin group, especially in liver and spleen where the difference had reached highly significant levels (P < 0.01). The gene discussed is TF; the disease is neoplasm.